The Scientist

» pharmaceuticals and developmental biology

Most Recent

image: Drug Pricing Incites Outrage

Drug Pricing Incites Outrage

By | September 22, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

image: Whaling Specimens, 1930s

Whaling Specimens, 1930s

By | September 1, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

image: Q&A: Placental Ponderings

Q&A: Placental Ponderings

By | August 27, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

image: TS Live: Pharma Feast

TS Live: Pharma Feast

By | August 26, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

image: Novartis Buys Rights to GSK MS Drug for $1 Billion

Novartis Buys Rights to GSK MS Drug for $1 Billion

By | August 24, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

image: Valeant Scoops Sprout for $1 Billion

Valeant Scoops Sprout for $1 Billion

By | August 24, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

image: Doctor Who Blocked Thalidomide Dies

Doctor Who Blocked Thalidomide Dies

By | August 11, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

image: FDA Approves 3-D–Printed Drug

FDA Approves 3-D–Printed Drug

By | August 4, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

1 Comment

image: A Case of Sexual Ambiguity, 1865

A Case of Sexual Ambiguity, 1865

By | August 1, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

image: Contributors

Contributors

By | August 1, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech